Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases · 2006–2022
A researcher in the Science corpus: 7 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Jacques-Eric Gottenberg's perspective
Ordered by how strongly the researchers Jacques-Eric Gottenberg trusts endorse each paper. Same corpus, a different order for every researcher.
- Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews (Cochrane Database of Systematic Reviews)
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms. (Blood)
- Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit.
- A Coefficient of Agreement for Nominal Scales
- A comparison of two time intervals for test-retest reliability of health status instruments. (Journal of Clinical Epidemiology)
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study (Annals of the Rheumatic Diseases)
- Treating rheumatoid arthritis to target: recommendations of an international task force (Annals of the Rheumatic Diseases)
- Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary… (Arthritis & Rheumatism)
- Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled… (Annals of the Rheumatic Diseases)
- New therapies for treatment of rheumatoid arthritis. (The Lancet)
Their papers
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update (2022) — 1,431 citations
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020) — 2,212 citations
- EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies (2019) — 614 citations
- FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries (2014) — 609 citations
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (2010) — 2,684 citations
- EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome (2009) — 932 citations
- Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. (2006) — 619 citations